VIRUS-DIRECTED ENZYME/PRODRUG THERAPY (VDEPT) - SELECTIVELY ENGINEERING DRUG-SENSITIVITY INTO TUMORS

被引：40

作者：

HUBER, BE

RICHARDS, CA

AUSTIN, EA

机构：

[1] Division of Cell Biology, Wellcome Research Laboratories, North Carolina, 27709, 3030 Cornwallis Road, Research Triangle Park

来源：

GENE THERAPY FOR NEOPLASTIC DISEASES | 1994年 / 716卷

关键词：

D O I：

10.1111/j.1749-6632.1994.tb21706.x

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

[No abstract available]

引用

页码：104 / 114

页数：11

共 18 条

[1]

AUSTIN EA, 1993, MOL PHARMACOL, V43, P380

[2] CANCER STATISTICS, 1991 [J].

BORING, CC ;

SQUIRES, TS ;

TONG, T .

CA-A CANCER JOURNAL FOR CLINICIANS, 1991, 41 (01) :19-36

[3] INVIVO GENE-TRANSFER WITH RETROVIRAL VECTOR PRODUCER CELLS FOR TREATMENT OF EXPERIMENTAL BRAIN-TUMORS [J].

CULVER, KW ;

RAM, Z ;

WALLBRIDGE, S ;

ISHII, H ;

OLDFIELD, EH ;

BLAESE, RM .

SCIENCE, 1992, 256 (5063) :1550-1552

[4]

Daly J M, 1986, Important Adv Oncol, P251

[5]

DEVITA VT, 1982, CANCER PRINCIPLES PR

[6] INHIBITION BY ACYCLOVIR OF CELL-GROWTH AND DNA-SYNTHESIS OF CELLS BIOCHEMICALLY TRANSFORMED WITH HERPESVIRUS GENETIC INFORMATION [J].

FURMAN, PA ;

MCGUIRT, PV ;

KELLER, PM ;

FYFE, JA ;

ELION, GB .

VIROLOGY, 1980, 102 (02) :420-430

[7]

Gilman AG., 1990, J MED CHEM, V8th, DOI DOI 10.1021/acs.jmedchem.8b01308

[8]

HUBER BE, 1993, CANCER RES, V53, P4619

[9] RETROVIRAL-MEDIATED GENE-THERAPY FOR THE TREATMENT OF HEPATOCELLULAR-CARCINOMA - AN INNOVATIVE APPROACH FOR CANCER-THERAPY [J].

HUBER, BE ;

RICHARDS, CA ;

KRENITSKY, TA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (18) :8039-8043

[10]

HUBER BE, IN PRESS P NATL ACAD

← 1 2 →